Intuitive Surgical, Inc. (ISRG) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Intuitive Surgical, Inc. (ISRG)

ISRG 533.63

+0.7%

10:07 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: semi_infinite	4/10/2019 12:00:14 PM
	of 438

TRXC/ISRG - head to head comparison data between Senhance and Da Vinci Xi. I am shocked about how much better Senhance did in the TAPP case series submitted to FDA for clearance (complications, length of hospital stay) because the Da Vinci surgeons presumably has lots of procedures already under their belts using the older Si system compared to Senhance users who included learning curve cases. See Table 4 in first link. Table 3 is lap chole comparison and that includes Si and Xi cases. (posted on iHub yesterday and made some edits for this board to add clarity). Senhance label expansion 510K data. (tables 3 and 4) accessdata.fda.gov Da Vinci Xi 510K data. accessdata.fda.gov

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next